SMMT - Summit Therapeutics Inc
IEX Last Trade
13
0.140 1.077%
Share volume: 2,106,166
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$12.86
0.14
1.09%
Summary score
25%
Profitability
25%
Dept financing
12%
Liquidity
75%
Performance
16%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2019 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-51.17%
Return on assets
-30.24%
Return on sales
-12039.37%
Return on invested capital
45.52%
Total debt ratio
37.61%
Debt ratio change over timeo
-0.9%
Current Ratio
7.32%
Quick Ratio
8.36%
Cash Position Ratio
5.78%
Short-term ratios 30-Jun-2022 - 30-Jun-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-112.47%
Return on assets
-57.52%
Return on sales
-7700%
Return on invested capital
1126.06%
Total debt ratio
48.1%
Debt ratio change over timeo
-0.51%
Current Ratio
14.61%
Quick Ratio
14.61%
Cash Position Ratio
12.05%
Last quarter ratios 30-Jun-2023
The data are presented for the financials results of the last quarter.
Return on equity
-12.31%
Return on assets
-6.65%
Return on sales
0%
Return on invested capital
714.42%
Total debt ratio
49.62%
Debt ratio change over time
0.63%
Current Ratio
19.07%
Quick Ratio
19.07%
Cash Position Ratio
18.02%
Performance ratios (change over 4 years) 30-Jun-2019 - 30-Jun-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-107.08%
Return on assets
-102.08%
Return on sales
-993.8%
Return on invested capital
59.36%
Total debt ratio
-89.99%
Debt ratio change over time
-0.9%
Current Ratio
4.42%
Quick Ratio
6.91%
Cash Position Ratio
4.24%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SMMT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -51.17% | 5.24% | 35.86% | 7.9% |
| Return on assets | -30.24% | 3.12% | 3.56% | 5.95% |
| Return on sales | -12039.37% | 31.5% | 36.15% | 41.33% |
| Return on invested capital | 45.52% | 4.08% | 6.32% | 20.63% |
| Profitability | 25% | 38% | 65% | 67% |
| Total debt ratio | 37.61% | 93.78% | 88.68% | 27.19% |
| Debt ratio change over time | -0.9% | 291.08% | 15.01% | 0.97% |
| Dept financing | 10% | 50% | 25% | 7% |
| Current Ratio | 14.61% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 14.61% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 12.05% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 10% | 15% | 33% |
| Short-term ratios | SMMT | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -112.47% | 14.06% | 44.07% | 4.73% |
| Return on assets | -57.52% | 3.29% | 3.18% | 3.77% |
| Return on sales | -7700% | 32% | 34.58% | 34.56% |
| Return on invested capital | 1126.06% | 2.77% | 7.32% | 10.76% |
| Profitability | 25% | 53% | 71% | 53% |
| Total debt ratio | 48.1% | 89.22% | 93.78% | 22.11% |
| Debt ratio change over time | -0.51% | 98.45% | 12.55% | 1.14% |
| Dept financing | 13% | 49% | 28% | 6% |
| Current Ratio | 14.61% | 0.94% | 2.25% | 5.33% |
| Quick Ratio | 14.61% | 0.82% | 1.93% | 4.53% |
| Cash Position Ratio | 12.05% | 0.3% | 1.4% | 2.67% |
| Liquididy | 75% | 4% | 10% | 22% |